Publications
5674 Results
- Journal / Conference
- Leukemia 28(10):1969-1977;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24721792
- PMC
- PMC4167978
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia
- Journal / Conference
- Leukemia 28(2):269-277;
- Year
- 2014
- Research Committee(s)
- Myeloma
- PMID
- PMID23974982
- PMC
- n/a - review article
IMWG consensus on risk stratification in multiple myeloma
- Journal / Conference
- Cancer Medicine 3(5):1275-1283;
- Year
- 2014
- Research Committee(s)
- Myeloma
- PMID
- PMID24913924
- PMC
- PMC4302677
- Study Number(s)
- S0434
A phase II trial of BAY 43-9006 (Sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434
- Journal / Conference
- European Urology 65(2):372-377;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID23850254
- PMC
- not available
- Study Number(s)
- 30904
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr 295); ASCO Genitourinary Cancers Symposium (Jan 30-Feb 1, 2014, San Francisco , poster
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1011
Pre-randomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended vs. standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr297); ASCO Genitourinary Cancer Symposium, poster presentation;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Optimizing a risk stratification for local-regional failure after radical cystectomy using the SWOG 8710 cohort
- Journal / Conference
- British Journal of Cancer 111(6):1241-1248;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25117820
- PMC
- PMC4453857
- Study Number(s)
- CTSU/E2100
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
- Journal / Conference
- Journal of the National Cancer Institute 106(3):djt456;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24563519
- PMC
- PMC3975165
- Study Number(s)
- S0000
Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention 23(8):1494-1504;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24732629
- PMC
- PMC4119495
- Study Number(s)
- S0000
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- British Journal of Haematology May;165(4):504-509;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24579885
- PMC
- PMC4209396
- Study Number(s)
- S0910